Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv statistics
47 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- Feb 27, 2026
- Fundamentals through
- Jul 31, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- -0.12%
- 1.02%
- Shares Change (QoQ)
- 0.00%
- 0.00%
- Float
- 20M
- 27M
- Shares Held by Insiders
- 10.8%
- 4.27%
MarginsIndustry
- Pretax Margin
- 2.84%
- 2.70%
- EBITDA Margin
- -1.02%
- 3.79%
- FCF Margin
- -4.44%
- 5.92%
Returns on capitalIndustry
- Return on Equity (ROE)
- 2.25%
- 1.76%
- Return on Assets (ROA)
- 2.01%
- -2.60%
- Return on Invested Capital (ROIC)
- -9.44%
- 5.25%
- Return on Capital Employed (ROCE)
- -1.48%
- 3.71%
Financial positionIndustry
- Current Ratio
- 11.30
- 1.36
- Quick Ratio
- 11.06
- 0.75
GrowthIndustry
- Revenue Growth (YoY)
- 3.25%
- 5.34%
- Revenue Growth (3Y CAGR)
- -22.6%
- 5.14%
- Revenue Growth (5Y CAGR)
- -16.0%
- 7.65%
EfficiencyIndustry
- Asset Turnover
- 0.76
- 0.82
- Revenue Per Employee
- $49.91K
- $215.67K
- Profits Per Employee
- $1.32K
- -$534
- Employee Count
- 190
- 99
Income statement (TTM)Industry
- Pretax Income
- $269.00K
- -$31.25K
Balance sheetIndustry
- Net Cash (Debt)
- $8.58M
- $15.49K
- Net Cash Per Share
- $0.37
- $0.00
- Equity (Book Value)
- $10.44M
- $10.55M
- Book Value Per Share
- $0.46
- $0.73
- Tangible Book Value
- $10.44M
- $13.82K
- Working Capital
- $10.24M
- $4.37M
Cash flow (TTM)Industry
- Capital Expenditures
- -$6.47K
- -$6.55M
- FCF Per Share
- -$0.02
- $0.47
Taxes and interestIndustry
- Income Tax
- $17.47K
- $1.16M
- Effective Tax Rate
- 6.50%
- 24.1%
Scores and fair valueIndustry
- Graham Number
- $0.32
- $19.24
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- -2.93
- -2.75
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | PBSV | S&P 500 | Difference | PBSV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.3% | +0.6% | +3.7 pts | ||
| 3 months | -4.0% | +3.4% | −7.4 pts | ||
| Year to date | -8.3% | +13.3% | −21.6 pts | ||
| 1 year | -10.2% | +16.6% | −26.8 pts | ||
| 3 years | -23.0% | +86.4% | −109.4 pts | -8.4% | +23.1% |
| 5 years | -14.5% | +81.9% | −96.3 pts | -3.1% | +12.7% |
| 10 years | +11.2% | +318.9% | −307.6 pts | +1.1% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M PBSV shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,008 | 0.0% | 3,367 | 1.0 |
| Oct 15, 2026 | 2,008 | +109.6% | 13,020 | 1.0 |
| Sep 30, 2026 | 958 | – | 6,545 | 1.0 |
| Dec 15, 2025 | 404 | – | 1,678 | 1.0 |
| Oct 31, 2025 | 1,907 | -77.6% | 6,776 | 1.0 |
| Oct 15, 2025 | 8,505 | -53.7% | 3,067 | 2.8 |
| Sep 30, 2025 | 18,384 | +318.6% | 25,533 | 1.0 |
| Sep 15, 2025 | 4,392 | – | 23,269 | 1.0 |
| Jul 31, 2025 | 213 | +67.7% | 14,798 | 1.0 |
| Jul 15, 2025 | 127 | +30.9% | 15,592 | 1.0 |
| Jun 30, 2025 | 97 | – | 5,050 | 1.0 |
| May 30, 2025 | 261 | +44.2% | 3,634 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?